Hematology NewsNo Matched Sibling Donor? Sickle Cell Experts Debate Next-Best OptionSeptember 16, 2024Bleeding DisordersCellular TherapyTransplant
Hematology NewsTreatment Options in MCL: What Are the Best Practices?September 12, 2024Mantle Cell LymphomaCellular TherapyCLLPatient & Survivor CareMixed Topics
Hematology NewsDebate: Should CAR T Best Be Used in Early MM Relapse?September 12, 2024Cellular TherapyMultiple Myeloma
Oncology PracticeA Simple Blood Test May Predict Cancer Risk in T2DSeptember 11, 2024Preventive CareBreast CancerGastrointestinal CancerPatient & Survivor CareMetastatic Breast CancerImmuno-oncologyGynecologic Cancer
Hematology NewsDebate: Should Patients With CLL Take Breaks From Targeted Therapies?September 11, 2024CLLPatient & Survivor Care
Oncology PracticeIvonescimab: Possible New First-Line Standard in PD-L1–Positive Advanced NSCLC?September 9, 2024Lung CancerPatient & Survivor Care
Hematology NewsCould Aspirin Avert Bad Outcomes in Leukemia?September 9, 2024ALLAMLCLLPatient & Survivor Care
Hematology NewsTo Choose the Best First-line Drug for CML, Consider Efficacy and CostSeptember 6, 2024CMLCLLBusiness of MedicinePatient & Survivor CareB Cell Lymphoma
Oncology PracticeSupport for Laser Treatment to Reduce NMSC Risk is IncreasingAugust 28, 2024Nonmelanoma Skin CancerPreventive Care
Oncology PracticeDiagnosing, Treating Rashes In Patients on Immune Checkpoint InhibitorsAugust 21, 2024MelanomaMixed TopicsImmunotherapyImmuno-oncology
Oncology PracticeOutcomes with CDK4/6 Inhibitors Vary in BCJuly 30, 2024Breast CancerPatient & Survivor CareASCO Breast Cancer
Oncology PracticeWhat Does Hormone Receptor Mean in BRCA-Associated BC?July 29, 2024ASCO Breast CancerBreast Cancer
Oncology PracticeBlack Women With Breast Cancer Face Clinical InequitiesJuly 26, 2024ASCO Breast CancerBreast CancerDiversity in Medicine
Oncology PracticeRisk Stratification May Work Well for FIT-Based CRC Screening in ElderlyJuly 25, 2024GI OncologyGastroenterologyPreventive CareGastrointestinal Cancer